Skip to main content
S 2187 117th Congress Senate Health Administrative law and regulatory procedures Aging Appropriations Budget deficits and national debt Cancer Child health Computers and information technology Department of Health and Human Services Drug safety, medical device, and laboratory regulation Drug therapy Education programs funding Environmental health Executive agency funding and structure Food and Drug Administration (FDA) Genetics Government trust funds Health care costs and insurance Health information and medical records Health personnel

National Biomedical Research Act

Introduced: June 23, 2021 Introduced by: Warren, Elizabeth Democratic · Massachusetts See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 23, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jun 23, 2021
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

National Biomedical Research Act

This bill establishes and makes deposits through FY2030 into the Biomedical Innovation Fund for initiatives at the National Institutes of Health and the Food and Drug Administration. The fund supports (1) research for disease prevention, diagnosis, and treatment; (2) research for diseases that disproportionally account for federal health care spending; (3) the development, review, and post-market surveillance of medical products; and (4) other innovative medical research.

What's happening now June 23, 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 1
  • HR 4124 Related bill National Biomedical Research Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 11
All 11 Democratic 10 Independent 1
D
Baldwin, Tammy
Wisconsin · Jun 23, 2021
 D
Blumenthal, Richard
Connecticut · Jun 23, 2021
 D
Booker, Cory A.
New Jersey · Jun 23, 2021
 D
Duckworth, Tammy
Illinois · Jun 23, 2021
 D
Kaine, Tim
Virginia · Jun 23, 2021
 D
Luján, Ben Ray
New Mexico · Jun 23, 2021
 D
Markey, Edward J.
Massachusetts · Jun 23, 2021
 D
Murphy, Christopher
Connecticut · Jun 23, 2021
 D
Padilla, Alex
California · Jun 23, 2021
 I
Sanders, Bernard
Vermont · Jun 23, 2021
 D
Van Hollen, Chris
Maryland · Jun 23, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2187: National Biomedical Research Act. 117th Congress. Open America. https://openamerica.io/bill/117-S-2187/
MLA
"S. 2187: National Biomedical Research Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-2187/.
Bluebook (legal)
S. 2187, 117th Cong. (2026), https://openamerica.io/bill/117-S-2187/.
Markdown link
[S. 2187: National Biomedical Research Act](https://openamerica.io/bill/117-S-2187/)
Report a problem